Close Menu

NEW YORK (GenomeWeb) – Transgenomic said today that it has received $1.15 million in proceeds from a note bridge financing.

The company will use the funds to complete its merger with Precipio Diagnostics, which is expected to close in the second quarter. The companies announced the intended merger, which will make Precipio a wholly owned subsidiary of Transgenomic, in October.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Mar
18
Sponsored by
Thermo Fisher Scientific

Viruses mutate as they strive to thrive in response to selective pressures.

Mar
29
Sponsored by
Thermo Fisher Scientific

Global genetic surveillance is vital for understanding the evolution of viral pathogens and monitoring for changes in transmissibility, virulence, disease pathology, and impact on the efficacy of diagnostic tests, therapeutics, and vaccines.

Mar
31
Sponsored by
MilliporeSigma

This webinar will outline the development and commercialization journey of a novel CRISPR-based SARS-CoV-2 test.